Previous close | 3.8000 |
Open | 3.9500 |
Bid | 3.7500 |
Ask | 4.0000 |
Strike | 80.00 |
Expiry date | 2026-01-16 |
Day's range | 3.9500 - 4.0500 |
Contract range | N/A |
Volume | |
Open interest | 394 |
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.